BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nevárez N, de Lecea L. Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation. F1000Res 2018;7:F1000 Faculty Rev-1421. [PMID: 30254737 DOI: 10.12688/f1000research.15097.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Gompf HS, Anaclet C. The neuroanatomy and neurochemistry of sleep-wake control. Curr Opin Physiol 2020;15:143-51. [PMID: 32647777 DOI: 10.1016/j.cophys.2019.12.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Deol P, Kozlova E, Valdez M, Ho C, Yang EW, Richardson H, Gonzalez G, Truong E, Reid J, Valdez J, Deans JR, Martinez-Lomeli J, Evans JR, Jiang T, Sladek FM, Curras-Collazo MC. Dysregulation of Hypothalamic Gene Expression and the Oxytocinergic System by Soybean Oil Diets in Male Mice. Endocrinology 2020;161:bqz044. [PMID: 31912136 DOI: 10.1210/endocr/bqz044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
3 Han Y, Yuan K, Zheng Y, Lu L. Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders. Neurosci Bull 2020;36:432-48. [PMID: 31782044 DOI: 10.1007/s12264-019-00447-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
4 Huang M, Chen C, Chen L, Chang H, Chen C, Lin S, Xu K. Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation. Psychopharmacology 2020;237:45-53. [DOI: 10.1007/s00213-019-05342-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Faesel N, Kolodziejczyk MH, Koch M, Fendt M. Orexin deficiency affects sociability and the acquisition, expression, and extinction of conditioned social fear. Brain Res 2021;1751:147199. [PMID: 33160959 DOI: 10.1016/j.brainres.2020.147199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Xiang J, Zhang S, Xu R, Chu H, Biswas S, Yu S, Miao D, Li W, Li S, Brown AJ, Yang H, Xu Y, Li B, Liu H. Elevated HB-EGF expression in neural stem cells causes middle age obesity by suppressing Hypocretin/Orexin expression. FASEB J 2021;35:e21345. [PMID: 33715219 DOI: 10.1096/fj.202001945R] [Reference Citation Analysis]
7 Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): The ultimate translational neuropeptides. J Intern Med 2022. [PMID: 35043499 DOI: 10.1111/joim.13406] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Subramanian S, Ravichandran M. Orexin receptors: Targets and applications. Fundam Clin Pharmacol 2021. [PMID: 34464995 DOI: 10.1111/fcp.12723] [Reference Citation Analysis]
9 Watts AG, Kanoski SE, Sanchez-Watts G, Langhans W. The Physiological Control of Eating: Signals, Neurons, and Networks. Physiol Rev 2021. [PMID: 34486393 DOI: 10.1152/physrev.00028.2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
10 Moriya S, Takahashi H, Masukawa D, Yamada M, Ishigooka J, Nishimura K. Dual orexin receptor antagonist (DORA-12) treatment affects the overall levels of Net/maoA mRNA expression in the hippocampus. J Pharmacol Sci 2021;145:198-201. [PMID: 33451754 DOI: 10.1016/j.jphs.2020.12.003] [Reference Citation Analysis]
11 Zhang XY, Peng SY, Shen LP, Zhuang QX, Li B, Xie ST, Li QX, Shi MR, Ma TY, Zhang Q, Wang JJ, Zhu JN. Targeting presynaptic H3 heteroreceptor in nucleus accumbens to improve anxiety and obsessive-compulsive-like behaviors. Proc Natl Acad Sci U S A 2020;117:32155-64. [PMID: 33257584 DOI: 10.1073/pnas.2008456117] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Castro DC, Bruchas MR. A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell. Neuron 2019;102:529-52. [PMID: 31071288 DOI: 10.1016/j.neuron.2019.03.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 17.7] [Reference Citation Analysis]
13 Medrano-martinez P, Peraita-adrados R. Neuropsychological Alterations in Narcolepsy with Cataplexy and the Expression of Cognitive Deficits. J Int Neuropsychol Soc 2020;26:587-95. [DOI: 10.1017/s1355617719001334] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Alakuijala A, Virkkala J, Maasilta P, Bachour A. Self-reported view on work capacity predicts abnormal Oxford Sleep Resistance Test results in patients with obstructive sleep apnea. J Clin Sleep Med 2021;17:669-74. [PMID: 33196435 DOI: 10.5664/jcsm.8998] [Reference Citation Analysis]
15 Zhou F, Yan XD, Wang C, He YX, Li YY, Zhang J, Wang ZJ, Cai HY, Qi JS, Wu MN. Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice. Neurobiol Aging 2020;91:66-75. [PMID: 32224066 DOI: 10.1016/j.neurobiolaging.2020.02.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
16 Anderson G, Rodriguez M, Reiter RJ. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells. Int J Mol Sci 2019;20:E5500. [PMID: 31694154 DOI: 10.3390/ijms20215500] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
17 Kupchik YM, Prasad AA. Ventral pallidum cellular and pathway specificity in drug seeking. Neurosci Biobehav Rev 2021;131:373-86. [PMID: 34562544 DOI: 10.1016/j.neubiorev.2021.09.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Boss C, Gatfield J, Brotschi C, Heidmann B, Sifferlen T, von Raumer M, Schmidt G, Williams JT, Treiber A, Roch C. The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders. ChemMedChem 2020;15:2286-305. [PMID: 32937014 DOI: 10.1002/cmdc.202000453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Katzman MA, Katzman MP. Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone. Brain Sciences 2022;12:150. [DOI: 10.3390/brainsci12020150] [Reference Citation Analysis]
21 Jennings KJ, de Lecea L. Neural and Hormonal Control of Sexual Behavior. Endocrinology 2020;161:bqaa150. [PMID: 32845294 DOI: 10.1210/endocr/bqaa150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
22 Borniger JC. Central regulation of breast cancer growth and metastasis. J Cancer Metastasis Treat 2019;5:23. [PMID: 31773065 DOI: 10.20517/2394-4722.2018.107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]